ZA915656B - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
ZA915656B
ZA915656B ZA915656A ZA915656A ZA915656B ZA 915656 B ZA915656 B ZA 915656B ZA 915656 A ZA915656 A ZA 915656A ZA 915656 A ZA915656 A ZA 915656A ZA 915656 B ZA915656 B ZA 915656B
Authority
ZA
South Africa
Prior art keywords
heterocyclic compounds
pharmaceutically acceptable
acceptable esters
ara
useful
Prior art date
Application number
ZA915656A
Other languages
English (en)
Inventor
Thomas Anthony Krenitsky
Anthony Krenitsky Thomas
Jeffrey Douglas Wilson
Douglas Wilson Jeffrey
George Walter Koszalka
Walter Koszalka George
David Porter
Porter David
Devron Randolph Averett
Randolph Averett Devron
Allan Ray Moorman
Ray Moorman Allan
Stanley Dawes Chamberlain
Dawes Chamberlain Stanley
Gerald Wolberg
Wolberg Gerald
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA915656B publication Critical patent/ZA915656B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Earth Drilling (AREA)
  • Stereophonic System (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
ZA915656A 1990-07-19 1991-07-18 Heterocyclic compounds ZA915656B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909015914A GB9015914D0 (en) 1990-07-19 1990-07-19 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
ZA915656B true ZA915656B (en) 1993-03-31

Family

ID=10679359

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915656A ZA915656B (en) 1990-07-19 1991-07-18 Heterocyclic compounds

Country Status (23)

Country Link
US (3) US5492897A (xx)
EP (1) EP0539479B1 (xx)
JP (1) JP2873086B2 (xx)
KR (1) KR100187326B1 (xx)
AT (1) ATE151637T1 (xx)
CA (1) CA2087543C (xx)
CY (1) CY2165B1 (xx)
DE (1) DE69125715T2 (xx)
DK (1) DK0539479T3 (xx)
ES (1) ES2103311T3 (xx)
GB (1) GB9015914D0 (xx)
GR (1) GR3023776T3 (xx)
HU (2) HU9300115D0 (xx)
IE (1) IE912513A1 (xx)
IL (1) IL98881A (xx)
MC (1) MC2289A1 (xx)
MY (1) MY111871A (xx)
NZ (1) NZ239025A (xx)
PT (1) PT98371B (xx)
RU (1) RU2114860C1 (xx)
TW (1) TW208655B (xx)
WO (1) WO1992001456A1 (xx)
ZA (1) ZA915656B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
WO1998042352A1 (en) * 1997-03-24 1998-10-01 Glaxo Group Ltd. Method for treating b-cell tumors with ara-g nucleoside derivatives
ES2284256T3 (es) * 1998-07-02 2007-11-01 Kyowa Hakko Kogyo Co., Ltd. Medicamentos para la diabetes.
US6753322B2 (en) * 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
AU2002365412B2 (en) * 2001-11-27 2008-10-09 Anadys Pharmaceuticals, Inc. 3-Beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
WO2004012746A2 (en) * 2002-08-02 2004-02-12 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
ATE465742T1 (de) 2003-09-05 2010-05-15 Anadys Pharmaceuticals Inc Tlr7-liganden zur behandlung von hepatitis c
GB0321613D0 (en) * 2003-09-15 2003-10-15 Drug Discovery Lab As Compounds
WO2006030217A2 (en) * 2004-09-15 2006-03-23 Drug Discovery Laboratory As Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
US20090082304A1 (en) * 2004-11-12 2009-03-26 Northwestern University Methods of Treating Hematological Malignancies with Nucleoside Analog Drugs
ES2525567T3 (es) 2004-12-17 2014-12-26 Anadys Pharmaceuticals, Inc. Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos
US20060189543A1 (en) * 2005-02-23 2006-08-24 Rosenbloom Richard A Compositions and methods for the treatment of leukemia
BRPI0618789A2 (pt) 2005-11-21 2016-08-30 Anadys Pharmaceuticals Inc processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona
DE602007012247D1 (de) * 2006-06-22 2011-03-10 Anadys Pharmaceuticals Inc Prodrugs von 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
BRPI0714831A2 (pt) 2006-07-18 2013-04-02 Anadys Pharmaceuticals Inc composto, composiÇço farmacÊutica e mÉtodos de modulaÇço de atividades imuno da citoquina em paciente, de tratamento de infecÇço de vÍrus c da hepatite em paciente e de desordem relacionada com proliferaÇço em mamÍfero necessitado do mesmo
CN101768197A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 一种奈拉滨的制备方法
EP2658857B1 (en) 2010-12-29 2016-11-02 Inhibitex, Inc. Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
WO2018230479A1 (ja) * 2017-06-13 2018-12-20 大原薬品工業株式会社 ヌクレオシド系抗がん剤又は抗ウィルス剤の５'位シリルエーテル誘導体
KR20230127294A (ko) * 2020-12-30 2023-08-31 서던 유니버시티 오브 사이언스 앤드 테크놀로지 코로나 바이러스 감염을 치료하기 위한 방법 및 변형된뉴클레오사이드

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2152486A1 (de) * 1970-11-20 1972-06-29 Akad Wissenschaften Ddr Verfahren zur Herstellung von 5'-Desoxy-5'-fluor-6-methyl-mercaptopurinribosid
US3872084A (en) * 1972-10-10 1975-03-18 Syntex Inc Purine nucleoside 3,5-cyclicphosphate compounds
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
JPS61233696A (ja) * 1985-04-08 1986-10-17 Kanegafuchi Chem Ind Co Ltd ７−ヒドロキシグアニン誘導体及びその製造方法並びにそれを有効成分とする抗腫瘍剤
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
CA1317291C (en) * 1987-12-14 1993-05-04 Naeem Botros Hanna Antitumor 6-sulfenamide, 6-sulfinamide and 6-sulfonamide purines, purine nucleosides, purine nucleotides and related compounds
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds

Also Published As

Publication number Publication date
HU9300115D0 (en) 1993-04-28
EP0539479A1 (en) 1993-05-05
CA2087543A1 (en) 1992-01-20
KR100187326B1 (ko) 1999-05-01
JP2873086B2 (ja) 1999-03-24
HUT62911A (en) 1993-06-28
EP0539479B1 (en) 1997-04-16
AU8196091A (en) 1992-02-18
DE69125715D1 (de) 1997-05-22
CA2087543C (en) 1998-08-25
MY111871A (en) 2001-02-28
ATE151637T1 (de) 1997-05-15
JPH05508649A (ja) 1993-12-02
IE912513A1 (en) 1992-01-29
GR3023776T3 (en) 1997-09-30
GB9015914D0 (en) 1990-09-05
NZ239025A (en) 1993-08-26
DE69125715T2 (de) 1997-08-07
US5492897A (en) 1996-02-20
AU641533B2 (en) 1993-09-23
PT98371A (pt) 1992-06-30
IL98881A0 (en) 1992-07-15
ES2103311T3 (es) 1997-09-16
IL98881A (en) 1996-01-19
MC2289A1 (fr) 1993-07-14
DK0539479T3 (da) 1997-08-25
TW208655B (xx) 1993-07-01
WO1992001456A1 (en) 1992-02-06
US5747472A (en) 1998-05-05
PT98371B (pt) 1999-01-29
RU2114860C1 (ru) 1998-07-10
CY2165B1 (en) 2002-08-23
US5821236A (en) 1998-10-13

Similar Documents

Publication Publication Date Title
CY2165B1 (en) Heterocyclic compounds
CA2272705A1 (en) Fused bicyclic pyrimidine derivatives
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
MY108616A (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines of piperazines, and compositions and methods of use thereof
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
MY102986A (en) Benzo (5,6) cycloheptapyridines, compositions and methods of use
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
RU93004860A (ru) Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция
HU912013D0 (en) Process for the production of benzopyrane derivatives and their heterocyclic analogues, antiyschemic medical preparations
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
AU563762B2 (en) S-adenosyl-l-methionine salts preparation
MY104124A (en) Therapeutic compounds.
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
MX9605131A (es) Formulacion estable de lactona de 7-etil-camptotecina y metodo para usar la misma.
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
JO2296B1 (en) Substituted pyrolates
ZA91901B (en) Side-chain homologous vitamin d derivatives,process for their production,pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
EP0523013A3 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
WO1998036778A8 (en) Sustained drug delivery and compositions useful therefor
AU7111587A (en) Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
JO2360B1 (en) Substituted pyrolates